Characterization of a KPC-84 harboring Klebsiella pneumoniae ST11 clinical isolate with ceftazidime-avibactam resistance

被引：0
|
作者：
Gong, Yanqiao [1 ,2 ]
Feng, Yu [1 ,3 ]
Zong, Zhiyong [1 ,3 ,4 ]
Lv, Xiaoju [1 ,4 ]
机构：
[1] Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu, Peoples R China
[2] Hubei Minzu Univ, Minda Hosp, Dept Infect Control, Enshi, Peoples R China
[3] Sichuan Univ, West China Hosp, Ctr Pathogen Res, Chengdu, Peoples R China
[4] Div Infect Dis, State Key Lab Biotherapy, Chengdu, Peoples R China
来源：
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 2024年 / 43卷 / 10期
基金：
中国国家自然科学基金;
关键词：
KPC; Ceftazidime-avibactam; Klebsiella pneumoniae;
D O I：
10.1007/s10096-024-04910-y
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
A novel KPC variant, KPC-84, identified in a Klebsiella pneumoniae isolate from China, exhibits a threonine (T) to proline (P) amino acid substitution at Ambler position 243(T243P), altering from the KPC-2 sequence. Cloning and expression of bla(KPC-84) in Escherichia coli, with subsequent MIC assessments, revealed increased resistance to ceftazidime-avibactam and significantly reduced carbapenemase activity compared to KPC-2. Kinetic measurements showed that KPC-84 exhibited sligthly higher hydrolysis of ceftazidime and reduced affinity for avibactam compared to KPC-2. This study emphasizes the emerging diversity of KPC variants with ceftazidime-avibactam resistance, underscoring the complexity of addressing carbapenem-resistant Klebsiella pneumoniae infections.
引用
收藏
页码：2029 / 2035
页数：7
相关论文
共 50 条
  • [11] KPC-Mediated Resistance to Ceftazidime-Avibactam and Collateral Effects in Klebsiella pneumoniae
    Findlay, Jacqueline
    Poirel, Laurent
    Juhas, Mario
    Nordmann, Patrice
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (09)
  • [12] Emergence of Ceftazidime-Avibactam Resistance and Decreased Virulence in Carbapenem-Resistant ST11 Klebsiella pneumoniae During Antibiotics Treatment
    Xu, Mengxin
    Qian, Changrui
    Jia, Huaiyu
    Feng, Luozhu
    Shi, Shiyi
    Zhang, Ying
    Wang, Lingbo
    Cao, Jianming
    Zhou, Tieli
    Zhou, Cui
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 6881 - 6891
  • [13] Ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae accompanied hypermucoviscosity acquisition
    Guo, Yingyi
    Wang, Jiong
    Yao, Likang
    Wang, Yijing
    Zhang, Yan
    Zhuo, Chuyue
    Yang, Xu
    Li, Feifeng
    Li, Jiahui
    Liu, Baomo
    He, Nanhao
    Chen, Jiakang
    Xiao, Shunian
    Lin, Zhiwei
    Zhuo, Chao
    BMC MICROBIOLOGY, 2024, 24 (01):
  • [14] Characterization of a Novel KPC-2 Variant, KPC-228, Conferring Resistance to Ceftazidime-Avibactam in an ST11-KL64 Hypervirulent Klebsiella pneumoniae
    Zhou, Peiyao
    Gao, Haojin
    Li, Meilan
    Wu, Chunyang
    Han, Weihua
    Wan, Cailing
    Shen, Li
    Yuan, Xinru
    Shi, Junhong
    Huang, Yu
    Lv, Jianbo
    Zhou, Ying
    Yu, Fangyou
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2025, 65 (03)
  • [15] Emergence of ceftazidime-avibactam resistance through in-vivo bla KPC-2 to bla KPC-33 conversion during treatment of ST11 Klebsiella pneumoniae associated infections
    Lai, Yi-Chyi
    Lin, Luo-Wei
    Lee, Yu-Lin
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 64 (02)
  • [16] Mutations in porin LamB contribute to ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae
    Guo, Yingyi
    Liu, Ningjing
    Lin, Zhiwei
    Ba, Xiaoliang
    Zhuo, Chuyue
    Li, Feifeng
    Wang, Jiong
    Li, Yitan
    Yao, Likang
    Liu, Baomo
    Xiao, Shunian
    Jiang, Ying
    Zhuo, Chao
    EMERGING MICROBES & INFECTIONS, 2021, 10 (01) : 2042 - 2051
  • [17] Identification of KPC-112 from an ST15 Klebsiella pneumoniae Strain Conferring Resistance to Ceftazidime-Avibactam
    Shen, Siquan
    Tang, Chengkang
    Ding, Li
    Han, Renru
    Yin, Dandan
    Yang, Weiwei
    Guo, Yan
    Hu, Fupin
    MSPHERE, 2022, 7 (06)
  • [18] Molecular mechanisms responsible KPC-135-mediated resistance to ceftazidime-avibactam in ST11-K47 hypervirulent Klebsiella pneumoniae
    Shi, Qingyu
    Shen, Siquan
    Tang, Chengkang
    Ding, Li
    Guo, Yan
    Yang, Yang
    Wu, Shi
    Han, Renru
    Yin, Dandan
    Hu, Fupin
    EMERGING MICROBES & INFECTIONS, 2024, 13 (01)
  • [19] Outbreak of Klebsiella pneumoniae ST11 Resistant To Ceftazidime-Avibactam Producing KPC-31 and the Novel Variant KPC-115 during COVID-19 Pandemic in Argentina
    Nicola, Federico
    Cejas, Daniela
    Gonzalez-Espinosa, Francisco
    Relloso, Silvia
    Herrera, Fabian
    Bonvehi, Pablo
    Smayevsky, Jorgelina
    Figueroa-Espinosa, Roque
    Gutkind, Gabriel
    Radice, Marcela
    MICROBIOLOGY SPECTRUM, 2022, 10 (06):
  • [20] Evolutionary Trajectories toward Ceftazidime-Avibactam Resistance in Klebsiella pneumoniae Clinical Isolates
    Carattoli, Alessandra
    Arcari, Gabriele
    Bibbolino, Giulia
    Sacco, Federica
    Tomolillo, Dario
    Di Lella, Federica Maria
    Trancassini, Maria
    Faino, Luigi
    Venditti, Mario
    Antonelli, Guido
    Raponi, Giammarco
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (10)
12345